Dihexa
Angiotensin IV analog studied in synaptogenesis and HGF/c-Met receptor research.
Angiotensin IV analog studied in synaptogenesis and HGF/c-Met receptor research.
The primary literature on this compound includes McCoy et al., J Pharmacol Exp Ther (2013). The references below link directly to the published record.
Every lot is synthesized in the USA, verified by HPLC, and ships with its Certificate of Analysis. It is supplied strictly for laboratory research use.
Research use only. Everything on this page describes laboratory research. This compound is supplied strictly for in-vitro research use; it is not approved by the FDA for human or veterinary use, and nothing here is a protocol or a recommendation.
Published research
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseasesWright JW, et al. Prog Neurobiol. 2015.PubMed →
- The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system
Further reading in the lab library
Researchers also ordered
- ARA-290Erythropoietin-derived 11-residue research peptide studied in neuropathy and tissue-protection literature.
- CartalaxSynthetic peptide bioregulator studied in joint and cartilage research models.
- DSIPDelta-sleep-inducing nonapeptide studied in sleep-architecture research.
- PinealonPineal-gland-derived synthetic tripeptide studied in cognitive-aging research.